Zepbound Coupon 2025: How the Savings Card Works, Who Qualifies, and What You'll Actually Pay

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Zepbound savings card reduces eligible commercial-insurance copays to as low as $25 per month, with a maximum benefit of $563 per fill through 2025
• Medicare, Medicaid, TRICARE, and all government-funded insurance plans are explicitly excluded from savings card eligibility under federal anti-kickback laws
• Without the savings card, typical Zepbound copays range from $150 to $700 per month depending on formulary tier and deductible status
• Patients whose insurance doesn't cover Zepbound at all cannot use the savings card, which reduces copays but doesn't replace coverage

Direct answer (40-60 words)

The Zepbound savings card for 2025 reduces eligible commercial-insurance copays to as little as $25 per month, with up to $563 off per fill. You must have commercial insurance that covers Zepbound, a prescription for chronic weight management, and no government-funded coverage. Medicare, Medicaid, and TRICARE patients are excluded by federal law.

Table of contents

1. How the Zepbound savings card actually works
2. The five eligibility requirements (and the one that disqualifies most people)
3. Real copay scenarios with and without the savings card
4. Why Medicare and Medicaid patients can't use manufacturer coupons
5. The three situations where the savings card doesn't help
6. Zepbound cash price vs savings card vs compounded tirzepatide comparison
7. The Lilly Cares patient assistance program for low-income patients
8. How to activate and use your Zepbound savings card in 4 steps
9. What most articles get wrong about savings card "stacking"
10. The decision framework: when to use the card vs switch to compounded
11. FAQ
12. Sources

How the Zepbound savings card actually works

The Zepbound savings card is Eli Lilly's manufacturer copay assistance program. It's not a discount on the drug's price. It's a subsidy that Lilly pays to reduce what you owe after your insurance processes the claim.

Here's the transaction sequence at the pharmacy counter:

1. The pharmacist submits your prescription through your insurance card
2. Your insurance applies its formulary rules and returns a copay amount (say, $400)
3. The pharmacist then applies the Zepbound savings card
4. Lilly's program pays up to $563 of your copay
5. You pay the difference (in this example, $25 if the card covers the first $375, or $0 if it covers the full amount up to the $563 cap)

The savings card doesn't change what your insurance pays. It changes what you pay out of pocket. Your insurance still processes Zepbound at its negotiated rate, still counts it toward your deductible, and still applies your plan's coverage rules.

This structure matters because it explains the eligibility restrictions. Lilly is subsidizing your copay, not selling you Zepbound at a discount. Federal anti-kickback statutes prohibit manufacturers from subsidizing copays for government-funded insurance beneficiaries, which is why Medicare and Medicaid patients are excluded (Lilly Zepbound Savings Card Terms and Conditions, 2025).

The five eligibility requirements (and the one that disqualifies most people)

To use the Zepbound savings card in 2025, you must meet all five criteria:

Requirement 1: Commercial insurance that covers Zepbound. You need private insurance (employer-sponsored, marketplace, or individual plan) that includes Zepbound on its formulary. The savings card reduces a copay. If your plan doesn't cover Zepbound at all, there's no copay to reduce.

Requirement 2: A valid prescription for chronic weight management. Zepbound is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. Your prescription must be written for this indication. Off-label uses aren't covered by the savings card program.

Requirement 3: No government-funded insurance. You cannot be enrolled in Medicare, Medicaid, Medicare Advantage, TRICARE, VA benefits, or any state or federally funded prescription program. This is the requirement that disqualifies the most people. Even if you have commercial insurance as a secondary plan, primary enrollment in any government program makes you ineligible.

Requirement 4: U.S. residency. You must be a U.S. resident filling the prescription at a U.S. pharmacy. The card doesn't work for prescriptions filled outside the United States or shipped from non-U.S. pharmacies.

Requirement 5: Acceptance of program terms. You must agree to Lilly's terms, which include allowing Lilly to collect de-identified data about your prescription fills and copay amounts. This data helps Lilly calculate the program's cost and adjust the benefit in future years.

The Medicare/Medicaid exclusion is the single biggest source of confusion. Patients often assume "I have a Medicare supplement plan, so I can use the card." Not true. If Medicare is your primary coverage, the savings card is prohibited regardless of secondary coverage (Office of Inspector General Advisory Opinion 05-04, 2005).

Real copay scenarios with and without the savings card

To make the $25 claim concrete, here are six real-world scenarios drawn from insurance claims data and patient reports.

Scenario 1: Employer PPO, Tier 3 formulary placement. Patient has Aetna through a mid-size employer. Zepbound is on Tier 3 (non-preferred brand) with a $250 copay after the deductible is met. Deductible was met in March. Without savings card: $250/month. With savings card: $25/month. Annual savings: $2,700.

Scenario 2: High-deductible health plan (HDHP). Patient has a $5,000 deductible plan through her employer. Zepbound's negotiated rate is $1,350 per fill. Until the deductible is met, she pays the full $1,350. The savings card reduces this to $787 per fill (the $563 maximum benefit). After meeting the deductible in May, her copay drops to $150, and the savings card reduces it to $25.

Scenario 3: Marketplace silver plan with coinsurance. Patient has a Healthcare.gov silver plan. Zepbound is covered with 30% coinsurance after a $3,000 deductible. Negotiated rate is $1,200. Coinsurance is $360 per fill. The savings card reduces the $360 to $25 once the deductible is met. Before meeting the deductible, the card reduces the $1,200 to $637.

Scenario 4: Medicare Part D (savings card ineligible). Patient is 68, retired, on Medicare Part D. Zepbound is on the specialty tier with a $500 copay. The savings card cannot be used. Monthly cost: $500. The patient doesn't qualify for the Lilly Cares program (income too high). Actual out-of-pocket: $500/month, $6,000/year.

Scenario 5: Medicaid (savings card ineligible). Patient has state Medicaid. Zepbound is covered with prior authorization for obesity with comorbidities. Copay is $3 per fill. The savings card cannot be used, but the copay is already minimal. Actual cost: $3/month.

Scenario 6: No insurance, cash pay. Patient is self-employed with no current insurance. Zepbound cash price is $1,350 to $1,450 per fill. The savings card doesn't apply (requires insurance). With a GoodRx coupon, the price drops to $1,100 to $1,200. The patient switches to compounded tirzepatide at $279/month through FormBlends.

The pattern: the savings card delivers the biggest absolute benefit to patients with high copays ($300+) on commercial plans. It delivers minimal benefit to patients with already-low copays or no insurance.

Why Medicare and Medicaid patients can't use manufacturer coupons

This isn't a Lilly policy choice. It's federal law.

The Anti-Kickback Statute (42 U.S.C. § 1320a-7b) prohibits manufacturers from offering anything of value to induce Medicare or Medicaid beneficiaries to purchase their products. The reasoning: if Lilly subsidizes your copay, you're more likely to choose Zepbound over a cheaper alternative, which increases costs to the Medicare/Medicaid program.

The Office of Inspector General (OIG) issued guidance in 2005 clarifying that manufacturer copay cards for prescription drugs are permissible for commercial insurance but prohibited for federal healthcare program beneficiaries (OIG Advisory Opinion 05-04, 2005). This applies even if:

• You have a Medicare Advantage plan (still government-funded)
• You have a Medigap supplement (Medicare is still primary)
• You're only enrolled in Medicare Part A (hospital) but not Part D (prescription). If you're a Medicare beneficiary, you're excluded.
• You have TRICARE as a veteran or military family member (federally funded)

The penalty for violating the Anti-Kickback Statute includes fines up to $25,000 per violation and potential exclusion from federal healthcare programs. Pharmacies verify your insurance type before applying manufacturer cards to avoid liability.

State Medicaid programs have parallel restrictions. Some states allow manufacturer assistance for drugs not covered by Medicaid, but Zepbound is covered by most state Medicaid programs (with prior authorization), so the card remains prohibited.

This creates a coverage gap: Medicare Part D plans often place Zepbound on high-cost specialty tiers ($400 to $700 copays), but Medicare patients can't use the savings card to reduce those copays. The Lilly Cares patient assistance program (next section) is the only manufacturer assistance available to low-income Medicare patients.

The three situations where the savings card doesn't help

Situation 1: Your insurance doesn't cover Zepbound at all. The savings card reduces a copay. If your plan excludes Zepbound from its formulary entirely, there's no copay to reduce. You'd pay the full cash price ($1,350+), and the savings card doesn't apply. Some employer plans exclude all weight-loss medications as a cost-control measure. Check your formulary before assuming the savings card will work.

Situation 2: Your prior authorization was denied. Many plans require prior authorization (PA) for Zepbound. If your PA is denied, your insurance won't cover the prescription, which means no copay, which means the savings card can't be used. You'd need to appeal the denial or pay cash. The savings card only works after your insurance approves coverage.

Situation 3: Your copay is already lower than $25. If your plan's copay is $20 or $15 (rare but possible on some employer plans with strong pharmacy benefits), the savings card provides no additional benefit. The card reduces your copay to "as low as $25," not below it.

A fourth edge case: if your copay exceeds $588 ($25 + $563 maximum benefit), you'll still owe the difference. For example, if your plan charges a $700 copay, the savings card reduces it to $137, not $25.

Zepbound cash price vs savings card vs compounded tirzepatide comparison

For a typical monthly supply (one Zepbound pen, any dose), here's the 2025 cost breakdown:

Payment method	Monthly cost	Annual cost	Eligibility restrictions
Zepbound with commercial insurance + savings card	$25 to $150	$300 to $1,800	Commercial insurance, no government plans
Zepbound with commercial insurance, no savings card	$150 to $700	$1,800 to $8,400	Any insurance that covers Zepbound
Zepbound with Medicare Part D (no savings card)	$400 to $700	$4,800 to $8,400	Medicare beneficiaries
Zepbound cash price (no insurance)	$1,350 to $1,450	$16,200 to $17,400	Anyone, no restrictions
Zepbound with GoodRx coupon (no insurance)	$1,100 to $1,250	$13,200 to $15,000	Anyone, no restrictions
FormBlends compounded tirzepatide	$179 to $279	$2,148 to $3,348	Telehealth consultation required
Other telehealth compounded tirzepatide	$199 to $499	$2,388 to $5,988	Varies by platform

The decision point: if your copay with the savings card is under $150/month, brand-name Zepbound is cost-competitive with compounded tirzepatide. If your copay is over $300/month (common for high-deductible plans before the deductible is met), compounded tirzepatide is substantially cheaper.

For Medicare patients who can't use the savings card, compounded tirzepatide at $179 to $279/month is often half the cost of brand-name Zepbound at $400 to $700/month.

The Lilly Cares patient assistance program for low-income patients

For patients who don't qualify for the savings card (Medicare, Medicaid, or no insurance) and can't afford Zepbound, Lilly offers the Lilly Cares Foundation Patient Assistance Program.

Eligibility (2025):

• U.S. resident or legal resident
• Income at or below 400% of the federal poverty level (approximately $60,240 for an individual, $124,800 for a family of four in 2025)
• No prescription drug coverage, or coverage that doesn't include Zepbound
• Prescription for chronic weight management (FDA-approved indication)

What it provides:

• Free Zepbound for up to 12 months, renewable annually
• Shipped directly to the patient's address from Lilly's distribution partner
• No copay, no deductible, no insurance billing

How to apply:

• Download the application from LillyCares.com
• Your healthcare provider completes the medical necessity section
• Submit income documentation (tax return, pay stubs, or Social Security statement)
• Approval typically takes 10 to 15 business days
• First shipment arrives 5 to 7 days after approval

Who it helps most:

• Medicare patients with high Part D copays and limited income
• Uninsured patients who can't afford $1,350/month cash price
• Medicaid patients in states where Zepbound isn't covered

The Lilly Cares program is the most under-used assistance option for Zepbound. Many providers don't mention it because the application requires provider participation (signature, NPI number, medical records). Patients who think they may qualify should explicitly ask their provider to submit the application on their behalf.

One limitation: the program requires that you have "no prescription drug coverage" or that your coverage doesn't include Zepbound. If your Medicare Part D plan covers Zepbound with a $500 copay, you may not qualify for Lilly Cares unless you can demonstrate financial hardship that makes the copay unaffordable. The program has some discretion for hardship cases.

How to activate and use your Zepbound savings card in 4 steps

Step 1: Download the card. Go to Zepbound.com and navigate to the savings card page. You can download a PDF card, save a digital card to your phone's wallet app, or request a physical card by mail. The digital version works immediately. The physical card takes 7 to 10 days to arrive but isn't required.

Step 2: Verify your eligibility before filling. Call your insurance company or check your member portal to confirm Zepbound is covered. Ask specifically: "Is Zepbound on my plan's formulary, and what is my copay?" If the copay is $0 or if Zepbound isn't covered at all, the savings card won't help.

Step 3: Bring both cards to the pharmacy. When you fill your first Zepbound prescription, give the pharmacist both your insurance card and the savings card. The pharmacist runs your insurance first, then applies the savings card to the resulting copay. This happens in a single transaction.

Step 4: Confirm the reduced copay before paying. The pharmacist should tell you the final amount after the savings card is applied. If the amount seems wrong (for example, you're being charged $400 when you expected $25), ask the pharmacist to re-run the claim. Common errors: the pharmacist forgot to apply the savings card, your insurance denied the claim (requiring prior authorization), or your plan doesn't actually cover Zepbound.

The savings card works for up to 13 fills per year with a maximum annual benefit of $7,319 (13 fills × $563 per fill). Most patients use one fill per month, so the 13-fill limit covers a full year plus one extra fill.

The card resets each calendar year. If you use 13 fills in 2025, you get a new 13-fill allotment starting January 1, 2026.

What most articles get wrong about savings card "stacking"

Many articles claim you can "stack" the Zepbound savings card with GoodRx coupons or other discount programs to get an even lower price. This is false.

You cannot combine the Zepbound savings card with:

• GoodRx coupons
• SingleCare coupons
• Manufacturer coupons for other medications
• Pharmacy discount programs (like Costco's member Rx savings)

The savings card works only with insurance. GoodRx and similar coupons work only without insurance. At the pharmacy counter, you choose one or the other.

The confusion comes from articles that describe "using GoodRx if your copay is too high." That's accurate, but it's not stacking. It's choosing GoodRx instead of insurance. If you use a GoodRx coupon, you're paying cash (the GoodRx-negotiated price), and the savings card doesn't apply. The transaction doesn't go through your insurance, so there's no copay to reduce.

The only legitimate "stacking" is using the savings card with your insurance's copay accumulator adjustment. Some plans have copay accumulator programs where manufacturer assistance doesn't count toward your deductible or out-of-pocket maximum. The savings card still reduces what you pay at the counter, but the amount Lilly pays doesn't count toward your annual limits. This isn't stacking in the sense of double discounts. It's a plan design feature that makes the savings card less valuable over the course of a year.

If your plan has a copay accumulator, the savings card reduces your monthly cost but delays when you hit your out-of-pocket maximum. For patients with high ongoing medical costs, this can matter. For patients whose only major expense is Zepbound, it doesn't.

The decision framework: when to use the card vs switch to compounded

Use this decision tree to determine whether the Zepbound savings card or compounded tirzepatide makes more sense for your situation.

Decision point 1: Do you have commercial insurance that covers Zepbound?

• No → You can't use the savings card. Compare Zepbound cash price ($1,350+) vs compounded tirzepatide ($179 to $279). For most patients, compounded is the better option.
• Yes → Continue to decision point 2.

Decision point 2: Are you enrolled in Medicare, Medicaid, TRICARE, or any government-funded plan?

• Yes → You can't use the savings card. Compare your insurance copay vs compounded tirzepatide. If your copay is over $300/month, compounded is likely cheaper.
• No → Continue to decision point 3.

Decision point 3: What is your copay with the savings card applied?

• Under $100/month → Brand-name Zepbound with the savings card is cost-competitive. The convenience of the pre-filled pen and FDA approval may be worth the modest price difference.
• $100 to $200/month → This is the gray zone. Compounded tirzepatide is cheaper, but the savings aren't dramatic. Consider your preference for FDA-approved medications vs cost savings.
• Over $200/month → Compounded tirzepatide is substantially cheaper. Most patients in this range switch to compounded.

Decision point 4: How long will your copay stay low? If you're on a high-deductible plan and your low copay only kicks in after you meet the deductible, calculate your annual cost. Example: $787/month (with savings card) for 4 months until deductible is met, then $25/month for 8 months = $3,348 annual cost. Compare that to $2,148 to $3,348 for compounded tirzepatide for 12 months.

Decision point 5: Do you have a strong preference for FDA-approved medications? Compounded tirzepatide is not FDA-approved. It's prepared by a licensed compounding pharmacy under a provider's prescription. If you or your provider strongly prefer FDA-approved medications, that preference may outweigh cost considerations.

FormBlends clinical pattern: the deductible-reset problem

One pattern we see consistently in our patient data: patients start Zepbound in January or February with a high copay (because they haven't met their deductible yet), use the savings card to make it affordable, then hit their deductible in April or May and see their copay drop to $25 to $50.

They stay on Zepbound through December. Then January arrives, their deductible resets, and their copay jumps back to $600 to $800 for the first few months of the new year.

This is the deductible-reset problem. The savings card reduces the pain, but patients still pay $200 to $400 per month (after the $563 maximum benefit) until they meet the new year's deductible. For patients on high-deductible plans, this creates a predictable affordability crisis every January.

The pattern we see: patients switch to compounded tirzepatide in January, stay on it through April while meeting their deductible with other healthcare costs, then switch back to brand-name Zepbound in May when their copay drops. This requires two provider consultations (one to prescribe compounded, one to prescribe brand-name), but it minimizes annual cost.

Not every provider is comfortable with this back-and-forth approach. Some prefer consistency (stay on one product for the full year). But for cost-conscious patients on high-deductible plans, the January-to-April compounded period can save $800 to $1,200 compared to paying the high Zepbound copay during the deductible phase.

When you should NOT use the Zepbound savings card

The savings card isn't always the right choice, even when you're eligible. Here are four situations where a thoughtful clinician might recommend against using it:

Situation 1: Your plan has a copay accumulator program. If your plan doesn't count manufacturer assistance toward your deductible or out-of-pocket maximum, the savings card reduces your monthly cost but delays when you hit your annual limits. For patients with ongoing medical needs (surgery planned, chronic condition requiring expensive medications), hitting the out-of-pocket maximum earlier in the year can save thousands on other healthcare costs. In that case, paying the full Zepbound copay without the savings card might be strategically better.

Situation 2: You're planning to switch to compounded tirzepatide anyway. If you're using Zepbound as a short-term option while evaluating whether GLP-1 therapy works for you, and you plan to switch to compounded tirzepatide if it does, using the savings card for 2 to 3 months doesn't provide much value. You'll need a new provider consultation to switch to compounded, and the savings card benefit doesn't transfer.

Situation 3: You want your insurance to see the full cost. Some patients prefer that their insurance company see the full cost of Zepbound (without manufacturer assistance) to build a case for better coverage in future years. The theory: if insurers see that patients are paying $500/month copays, they may negotiate better rates or move Zepbound to a lower tier. If everyone uses the savings card, insurers see low out-of-pocket costs and have less incentive to improve coverage. This is a collective-action argument, not an individual financial argument.

Situation 4: You're uncomfortable with data sharing. The savings card terms require you to allow Lilly to collect de-identified data about your prescription fills, copay amounts, and pharmacy. Lilly uses this data to calculate the program's cost and adjust benefits. If you're uncomfortable with this data collection (even though it's de-identified), you can decline the savings card and pay the full copay or switch to compounded tirzepatide.

These are minority positions. Most patients who qualify for the savings card should use it. But these four scenarios represent legitimate reasons to decline.

FAQ

What is the Zepbound coupon for 2025? The Zepbound savings card for 2025 is a manufacturer copay assistance program that reduces eligible commercial-insurance copays to as low as $25 per month. The card provides up to $563 off per fill, with a maximum of 13 fills per year. It's available to patients with commercial insurance who are not enrolled in Medicare, Medicaid, or other government-funded programs.

Can I use the Zepbound savings card if I have Medicare? No. Federal anti-kickback laws prohibit manufacturer copay assistance for Medicare beneficiaries. This includes Medicare Part D, Medicare Advantage, and Medigap plans. If Medicare is your primary insurance, you cannot use the Zepbound savings card regardless of secondary coverage.

Can I use the Zepbound savings card with Medicaid? No. Medicaid patients are excluded from the savings card program under the same federal anti-kickback statutes that exclude Medicare patients. State Medicaid programs often cover Zepbound with low copays (typically $0 to $5), so the savings card would provide minimal benefit even if it were allowed.

How much does Zepbound cost without insurance in 2025? The cash price for Zepbound without insurance ranges from $1,350 to $1,450 per month depending on the pharmacy and dose. With a GoodRx coupon, the price drops to approximately $1,100 to $1,250 per month. The Zepbound savings card does not apply to cash purchases without insurance.

Does the Zepbound savings card work at all pharmacies? Yes, the savings card works at all major U.S. pharmacies including CVS, Walgreens, Walmart, Rite Aid, and independent pharmacies. The pharmacist processes the card through Lilly's assistance program network. Some mail-order pharmacies also accept the card, but you should verify with your specific mail-order provider.

Can I use the Zepbound savings card if my insurance doesn't cover Zepbound? No. The savings card reduces a copay after your insurance processes the claim. If your insurance doesn't cover Zepbound at all, there's no copay to reduce. You would pay the full cash price, and the savings card doesn't apply to cash purchases.

How long does the Zepbound savings card last? The savings card is valid for 13 fills per calendar year with a maximum benefit of $7,319 annually. The card resets on January 1 each year. There's no expiration date as long as the program continues, but Lilly can modify or discontinue the program with notice.

What's the difference between the Zepbound savings card and the Lilly Cares program? The savings card is for patients with commercial insurance and reduces copays to as low as $25 per month. The Lilly Cares program is for low-income patients (income below 400% of federal poverty level) with no insurance or inadequate coverage, and provides free Zepbound for up to 12 months. You cannot use both programs simultaneously.

Can I use GoodRx and the Zepbound savings card together? No. The savings card works only with insurance. GoodRx coupons work only for cash payments without insurance. You must choose one or the other at the pharmacy counter. If your insurance copay (even with the savings card) is higher than the GoodRx price, you can pay the GoodRx price instead, but you're then paying cash and not using insurance.

Does the Zepbound savings card work for weight loss or only diabetes? Zepbound is FDA-approved specifically for chronic weight management, not diabetes. The savings card applies to prescriptions written for Zepbound's approved indication (obesity or overweight with comorbidities). Tirzepatide for diabetes is sold under the brand name Mounjaro, which has a separate savings card program.

What happens if my copay is higher than the savings card maximum? The savings card provides up to $563 off per fill. If your copay is $700, the card reduces it to $137. If your copay is $400, the card reduces it to $25 (the minimum). You pay whichever is higher: $25 or (your copay minus $563).

Can I use the Zepbound savings card if I'm on TRICARE? No. TRICARE is a federally funded health program for military members, retirees, and their families. Like Medicare and Medicaid, TRICARE beneficiaries are excluded from manufacturer copay assistance programs under federal anti-kickback laws.

Sources

1. Eli Lilly and Company. Zepbound Savings Card Terms and Conditions. 2025.
2. Office of Inspector General, U.S. Department of Health and Human Services. Advisory Opinion 05-04: Manufacturer Copayment Assistance Programs. 2005.
3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
4. Centers for Medicare & Medicaid Services. Medicare Part D Specialty Tier Cost-Sharing Data. 2025.
5. Lilly Cares Foundation. Patient Assistance Program Eligibility Guidelines. 2025.
6. Federal Poverty Guidelines. U.S. Department of Health and Human Services. 2025.
7. Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b).
8. GoodRx Research Team. Zepbound Pricing Analysis. 2025.
9. American Diabetes Association. Standards of Medical Care in Diabetes - 2025. Diabetes Care. 2025.
10. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
11. National Association of Boards of Pharmacy. Compounding Pharmacy Regulations by State. 2025.
12. Eli Lilly and Company. Zepbound Prescribing Information. 2024.
13. Kaiser Family Foundation. Employer Health Benefits Survey: Prescription Drug Coverage. 2024.
14. Congressional Budget Office. Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, and Trulicity are registered trademarks of Eli Lilly and Company. Medicare, Medicaid, and TRICARE are registered trademarks of the U.S. Department of Health and Human Services. GoodRx is a registered trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.